Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02650752
Title Intermittent High-Dose Lapatinib in Tandem With Capecitabine for HER2 Overexpressed/Amplified Metastatic Breast Cancer With Central Nervous System (CNS) Metastases
Recruitment Completed
Gender female
Phase Phase I
Variant Requirements No
Sponsors Memorial Sloan Kettering Cancer Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Michigan Health System Ann Arbor Michigan 48109 United States Details
Memoral Sloan Kettering Cancer Center Basking Ridge New Jersey United States Details
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 United States Details
Memorial Sloan Kettering Cancer Center @ Suffolk Commack New York 11725 United States Details
Memorial Sloan Kettering Westchester Harrison New York 10604 United States Details
Queens Cancer Center of Queens Hospital Jamaica New York 11432 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering at Mercy Medical Center Rockville Centre New York United States Details
Memorial Sloan Kettering Nassau Uniondale New York 11553 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field